Teva Pharmaceutical Industries Ltd
TEVA15.575USD
+0.554+3.70%
Handelsschluss 04/29, 16:00（ET）Kurse um 15 Minuten verzögert
17.66BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Teva Pharmaceutical Industries Ltd Unternehmen
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Unternehmensinformationen
Unternehmens-codeTEVA
Name des UnternehmensTeva Pharmaceutical Industries Ltd
IPO-datumJan 01, 1951
Gegründet am1944
CEOMr. Richard D. Francis
Anzahl der mitarbeiter33892
WertpapierartOrdinary Share
GeschäftsjahresendeJan 01
Addresse124 Dvora Hanevi'a St.
StadtTEL AVIV-YAFO
BörseTel Aviv Stock Exchange
LandIsrael
Postleitzahl6944020
Telefon97239148213
Websitehttps://www.tevapharm.com/
Unternehmens-codeTEVA
IPO-datumJan 01, 1951
Gegründet am1944
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
12.87K
--
Mr. David R. McAvoy
Mr. David R. McAvoy
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
11.91K
--
Mr. Evan Lippman
Mr. Evan Lippman
Executive Vice President - Business Development
Executive Vice President - Business Development
--
--
Mr. Placid Jover
Mr. Placid Jover
Executive Vice President, Chief Human Resources Officer
Executive Vice President, Chief Human Resources Officer
--
--
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
--
--
Mr. Eliyahu Sharon (Eli) Kalif
Mr. Eliyahu Sharon (Eli) Kalif
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Matthew Shields
Mr. Matthew Shields
Executive Vice President - Teva Global Operations
Executive Vice President - Teva Global Operations
--
--
Mr. Chen Lichtenstein
Mr. Chen Lichtenstein
Independent Director
Independent Director
--
--
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
12.87K
--
Mr. David R. McAvoy
Mr. David R. McAvoy
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
11.91K
--
Mr. Evan Lippman
Mr. Evan Lippman
Executive Vice President - Business Development
Executive Vice President - Business Development
--
--
Mr. Placid Jover
Mr. Placid Jover
Executive Vice President, Chief Human Resources Officer
Executive Vice President, Chief Human Resources Officer
--
--
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
--
--
Umsatzaufteilung
Währung: USDUpdate-Zeit: Sun, Apr 6
Währung: USDUpdate-Zeit: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Generic products
9.46B
57.19%
AUSTEDO
1.69B
10.20%
Anda
1.54B
9.28%
Other
1.38B
8.32%
AJOVY
507.00M
3.06%
Other
1.98B
11.94%
Nach RegionUSD
Name
Umsatz
Anteil
United States
8.03B
48.56%
Europe
5.10B
30.85%
International Markets
2.46B
14.89%
Other
944.00M
5.71%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Generic products
9.46B
57.19%
AUSTEDO
1.69B
10.20%
Anda
1.54B
9.28%
Other
1.38B
8.32%
AJOVY
507.00M
3.06%
Other
1.98B
11.94%
Aktionäre
Update-Zeit: 13 hours ago
Update-Zeit: 13 hours ago
Aktionärsstatistik
Art
Aktionärsstatistik
Aktionäre
Anteil
Fidelity Management & Research Company LLC
6.63%
Clal Insurance Enterprises Holdings Ltd.
3.40%
Ion Asset Management Israel Ltd
3.20%
BlackRock Institutional Trust Company, N.A.
2.89%
Menora Mivtachim Insurance Ltd.
2.47%
Other
81.42%
Aktionärsstatistik
Aktionäre
Anteil
Fidelity Management & Research Company LLC
6.63%
Clal Insurance Enterprises Holdings Ltd.
3.40%
Ion Asset Management Israel Ltd
3.20%
BlackRock Institutional Trust Company, N.A.
2.89%
Menora Mivtachim Insurance Ltd.
2.47%
Other
81.42%
Art
Aktionäre
Anteil
Investment Advisor
25.91%
Investment Advisor/Hedge Fund
13.09%
Hedge Fund
12.84%
Insurance Company
4.75%
Research Firm
2.36%
Pension Fund
1.85%
Bank and Trust
0.94%
Family Office
0.81%
Sovereign Wealth Fund
0.20%
Other
37.25%
Institutionelle Beteiligung
Update-Zeit: Mon, Jan 20
Update-Zeit: Mon, Jan 20
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q1
1071
683.47M
59.65%
-18.19M
2024Q4
1087
683.52M
59.66%
-22.86M
2024Q3
1029
663.95M
58.60%
-6.13M
2024Q2
1002
631.05M
55.72%
-26.20M
2024Q1
950
595.83M
53.15%
-34.73M
2023Q4
932
601.27M
53.63%
+7.51M
2023Q3
929
573.53M
51.16%
-84.22M
2023Q2
921
512.98M
45.79%
-122.32M
2023Q1
927
576.84M
51.93%
-50.26M
2022Q4
946
573.39M
51.61%
-69.40M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Fidelity Management & Research Company LLC
76.01M
6.63%
+14.91M
+24.41%
Dec 31, 2024
Clal Insurance Enterprises Holdings Ltd.
38.96M
3.4%
+4.42M
+12.79%
Dec 31, 2024
Ion Asset Management Israel Ltd
36.65M
3.2%
+409.78K
+1.13%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
33.10M
2.89%
+786.74K
+2.43%
Dec 31, 2024
Menora Mivtachim Insurance Ltd.
28.38M
2.48%
-456.80K
-1.58%
Dec 31, 2024
Lingotto Investment Management LLP
27.19M
2.37%
+688.86K
+2.60%
Dec 31, 2024
Migdal Insurance and Financial Holdings Ltd
26.04M
2.27%
+569.41K
+2.24%
Dec 31, 2024
Phoenix Investment and Finances Ltd
21.21M
1.85%
-1.35M
-5.98%
Dec 31, 2024
State Street Global Advisors (US)
19.41M
1.69%
-86.64K
-0.44%
Dec 31, 2024
Mehr Anzeigen
Verbundene ETFs
Update-Zeit: Sun, Apr 6
Update-Zeit: Sun, Apr 6
Name
Anteil
VanEck Israel ETF
7.39%
iShares MSCI Israel ETF
7.06%
VanEck Pharmaceutical ETF
4.4%
Tema Neuroscience and Mental Health ETF
4.26%
Amplify Weight Loss Drug & Treatment ETF
3.49%
AdvisorShares Dorsey Wright ADR ETF
2.35%
ARK Israel Innovative Technology ETF
1.46%
Amplify International Enhanced Dividend Income ETF
1.33%
FIS Christian Stock Fund ETF
0.91%
Affinity World Leaders Equity ETF
0.9%
Mehr Anzeigen
VanEck Israel ETF
Anteil7.39%
iShares MSCI Israel ETF
Anteil7.06%
VanEck Pharmaceutical ETF
Anteil4.4%
Tema Neuroscience and Mental Health ETF
Anteil4.26%
Amplify Weight Loss Drug & Treatment ETF
Anteil3.49%
AdvisorShares Dorsey Wright ADR ETF
Anteil2.35%
ARK Israel Innovative Technology ETF
Anteil1.46%
Amplify International Enhanced Dividend Income ETF
Anteil1.33%
FIS Christian Stock Fund ETF
Anteil0.91%
Affinity World Leaders Equity ETF
Anteil0.9%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten